Abstract 2022-RA-435-ESGO Table 1

Summary of patient data

NoAgeFIGO stageInitial surgery/residualPFI (month)Prior chemoPSAcsitesSDS/residualWashing cytologyIntraperitoneal relapse after SDSOutcomeFollow up (month)
1 74 IVB IDS/0 mm 32 no 0 no 0 mm negative no NED 82
2 72 IIIC IDS/<10 mm 6 yes 1 no <10 mm positive yes DFD 16
3 82 IIIC PDS/0 mm 17 no 1 no 0 mm positive yes DFD 40
4 65 IIIC PDS/0 mm 81 yes 0 no 0 mm negative no NED 20**
5 66 IC PDS/0 mm 60 no 0 no 0 mm negative no LN meta/NED* 89
6 69 IIIC PDS/<10 mm 37 yes 0 no 0 mm negative no NED* 84
7 70 IIIB PDS/0 mm 44 no 1 no 0 mm positive yes DFD 36
8 53 IC PDS/0 mm 42 yes 0 no 0 mm negative no NED 108
9 73 IIIC IDS/0 mm 27 yes 0 no 0 mm negative no DFOD 78
10 72 IIIC PDS/0 mm 36 yes 0 no 0 mm negative no Brain meta/DFD 43
11 77 IIC PDS/0 mm 63 no 0 no 0 mm negative no DFOD 58
12 57 IIIC IDS/0 mm 27 yes 0 no 0 mm positive yes DFD 17
13 48 IIIC PDS/0 mm 23 yes 0 no 0 mm negative no NED 44**